Revisiting Sex Equality With Transcatheter Aortic Valve Replacement Outcomes: A Collaborative, Patient-Level Meta-Analysis of 11,310 Patients

• Published in: Journal of the American College of Cardiology 2015-07, Vol.66 (3), p.221-228
• Main Authors: O'Connor, Stephen A, Morice, Marie-Claude, Gilard, Martine, Leon, Martin B, Webb, John G, Dvir, Danny, Rodés-Cabau, Josep, Tamburino, Corrado, Capodanno, Davide, D'Ascenzo, Fabrizio, Garot, Philippe, Chevalier, Bernard, Mikhail, Ghada W, Ludman, Peter F
• Format: Article
• Language: English
• Subjects: Aged; Aged, 80 and over; Aortic Valve - surgery; Aortic Valve Stenosis - diagnosis; Aortic Valve Stenosis - surgery; Female; Heart Valve Prosthesis; Hemorrhage - epidemiology; Hemorrhage - etiology; Humans; Incidence; Male; Outcome Assessment (Health Care); Patient Selection; Postoperative Complications - epidemiology; Risk Factors; Severity of Illness Index; Sex Factors; Stroke - epidemiology; Stroke - etiology; Survival Analysis; Transcatheter Aortic Valve Replacement - adverse effects; Transcatheter Aortic Valve Replacement - methods; Transcatheter Aortic Valve Replacement - mortality
• ISSN: 1558-3597
• DOI: 10.1016/j.jacc.2015.05.024

There has been conflicting clinical evidence as to the influence of female sex on outcomes after transcatheter aortic valve replacement. The aim of this study was to evaluate the impact of sex on early and late mortality and safety end points after transcatheter aortic valve replacement using a collaborative meta-analysis of patient-level data. From the MEDLINE, Embase, and the Cochrane Library databases, data were obtained from 5 studies, and a database containing individual patient-level time-to-event data was generated from the registry of each selected study. The primary outcome of interest was all-cause mortality. The safety end point was the combined 30-day safety end points of major vascular complications, bleeding events, and stroke, as defined by the Valve Academic Research Consortium when available. Five studies and their ongoing registry data, comprising 11,310 patients, were included. Women constituted 48.6% of the cohort and had fewer comorbidities than men. Women had a higher rate of major vascular complications (6.3% vs. 3.4%; p < 0.001), major bleeding events (10.5% vs. 8.5%; p = 0.003), and stroke (4.4% vs. 3.6%; p = 0.029) but a lower rate of significant aortic incompetence (grade ≥2; 19.4% vs. 24.5%; p < 0.001). There were no differences in procedural and 30-day mortality between women and men (2.6 % vs. 2.2% [p = 0.24] and 6.5% vs. 6.5% [p = 0.93], respectively), but female sex was independently associated with improved survival at median follow-up of 387 days (interquartile range: 192 to 730 days) from the index procedure (adjusted hazard ratio: 0.79; 95% confidence interval: 0.73 to 0.86; p = 0.001). Although women experience more bleeding events, as well as vascular and stroke complications, female sex is an independent predictor of late survival after transcatheter aortic valve replacement. This should be taken into account during patient selection for this procedure.